Skip to content
AI情报Mar 17, 2026Secondary Market
文章

国药一致

China National Accord Medicines released a preliminary 2025 performance report. Revenue slightly declined 1.29% to RMB 73.416 billion, but net profit surged 76.8% to RMB 1.136 billion. Basic earnings per share were RMB 2.04.

Data Cube AI 编辑部来源: 36Kr
01

来源简报

China National Accord Medicines released a preliminary 2025 performance report. Revenue slightly declined 1.29% to RMB 73.416 billion, but net profit surged 76.8% to RMB 1.136 billion. Basic earnings per share were RMB 2.04.

02